At a glance
- Originator Ocean Biotechnology
- Class Antibacterials; Lactones; Macrolides; Small molecules
- Mechanism of Action Protein 50S ribosomal subunit inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Bacterial infections
Most Recent Events
- 13 Jun 2001 No-Development-Reported for Bacterial infections in Japan (Unknown route)
- 23 Jul 1998 New profile
- 23 Jul 1998 Preclinical development for Bacterial infections in Japan (Unknown route)